TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bionord Biokemi AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 5,895 | 6,267 | 5,194 |
Financial expenses | 0 | 1 | 2 |
Earnings before taxes | 635 | 644 | 656 |
EBITDA | 635 | 649 | 664 |
Total assets | 2,245 | 2,593 | 2,366 |
Current assets | 2,020 | 2,363 | 2,110 |
Current liabilities | 651 | 1,082 | 862 |
Equity capital | 1,349 | 1,285 | 1,281 |
- share capital | 45 | 45 | 49 |
Employees (average) | 6 | 5 | 5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 60.1% | 49.6% | 54.1% |
Turnover per employee | 982 | 1,253 | 1,039 |
Profit as a percentage of turnover | 10.8% | 10.3% | 12.6% |
Return on assets (ROA) | 28.3% | 24.9% | 27.8% |
Current ratio | 310.3% | 218.4% | 244.8% |
Return on equity (ROE) | 47.1% | 50.1% | 51.2% |
Change turnover | -390 | 1,494 | -497 |
Change turnover % | -6% | 31% | -9% |
Chg. No. of employees | 1 | 0 | 0 |
Chg. No. of employees % | 20% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.